Y10S 977/808
Exterior attachment for targeting
Official title: Exterior attachment for targeting, e.g. drug targeting
Y10S977/808 (Exterior attachment for targeting) appears on 44 US grants and 17 published applications in this corpus.
Search patents in Y10S- Granted patents
- 44
- Published applications
- 17
- Assignees
- 32
- Inventors
- 77
- Latest grant
- 24 Dec 2013
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1992 | 1 | 0 |
| 1993 | 0 | 0 |
| 1994 | 0 | 0 |
| 1995 | 1 | 0 |
| 1996 | 2 | 0 |
| 1997 | 1 | 0 |
| 1998 | 4 | 0 |
| 1999 | 2 | 0 |
| 2000 | 7 | 0 |
| 2001 | 4 | 0 |
| 2002 | 5 | 2 |
| 2003 | 5 | 1 |
| 2004 | 2 | 2 |
| 2005 | 1 | 2 |
| 2006 | 0 | 1 |
| 2007 | 0 | 3 |
| 2008 | 1 | 1 |
| 2009 | 1 | 1 |
| 2010 | 0 | 1 |
| 2011 | 3 | 2 |
| 2012 | 3 | 1 |
| 2013 | 1 | 0 |
By publication year. Applications have been published since 2001.
Recent patents
- Methods and compositions for targeting agents into and across the blood-brain barrier and other endothelial cell microvascular barriers24 Dec 2013US 8,613,929 B2To-Bbb Holding B.V.
- Therapeutic inhibitor of vascular smooth muscle cells17 Apr 2012US 8,158,670 B2Boston Scientific Scimed, Inc.
- Methods and compositions for imaging17 Jan 2012US 8,097,283 B2Mount Sinai School of Medicine
- Therapeutic inhibitor of vascular smooth muscle cells17 Jan 2012US 8,097,642 B2Boston Scientific Scimed, Inc.
- Methods and compositions for targeting agents into and across the blood-barrier and other endothelial cell microvascular barriers27 Sep 2011US 8,026,209 B2BBB Holding B.V.
- Therapeutic Inhibitor of Vascular Smooth Muscle Cells2 Aug 2012US 2012/0195951 A1
- Therapeutic Inhibitor of Vascular Smooth Muscle Cells8 Dec 2011US 2011/0300221 A1
- Methods and compositions for targeting agents into and across the blood-brain barrier and other endothelial cell microvascular barriers10 Nov 2011US 2011/0274749 A1BBB Holding B.V.
- Eukaryotic Layered Vector Initiation Systems8 Jul 2010US 2010/0173412 A1Novartis Vaccines and Diagnostics, Inc.
- High-Efficiency Fusogenic Vesicles, Methods of Producing Them, and Pharmaceutical Compositions Containing Them12 Nov 2009US 2009/0280163 A1Pevion Biotech Ltd.
Most cited
By later US patents
- Therapeutic inhibitor of vascular smooth muscle cells245US 6,171,609 B2NeoRx Corporation · 2001
- Eukaryotic layered vector initiation systems204US 5,814,482 A1998
- Therapeutic inhibitor of vascular smooth muscle cells171US 6,515,009 B1NeoRx Corporation · 2003
- Alphavirus vector constructs167US 5,843,723 AChiron Corporation · 1998
- Alphavirus structural protein expression cassettes152US 5,789,245 AChiron Corporation · 1998